Beta Bionics, Inc. (BBNX) vs Bioventus Inc. (BVS)
Beta Bionics, Inc. and Bioventus Inc. are both Medical Devices companies. Beta Bionics, Inc. and Bioventus Inc. are of similar size ($1.2B and $1.1B). Beta Bionics, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 17.0×. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −61.3%) and the higher return on invested capital (7.34% vs −68.5%). Across the 17 metrics below, Bioventus Inc. leads on 14 and Beta Bionics, Inc. on 3.
Valuation
Profitability
| Metric | BBNX | BVS | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.31% | 68.65% | 56.01% |
| Operating margin | (69.75%) | 10.02% | (15.03%) |
| Net margin | (61.32%) | 9.36% | (20.40%) |
| Free cash flow margin | (284.13%) | 16.20% | (7.24%) |
| Return on equity | (26.16%) | 22.75% | (15.32%) |
| Return on assets | (23.45%) | 7.89% | (19.72%) |
| Return on invested capital | (68.47%) | 7.34% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack